Article

wkrg.com on 2016-01-05 20:30

Merck CEO: Eager for deals, strong prospects for new drugs

Related news

Merck CEO: Eager for deals, strong prospects for new drugs seattletimes.com
New Jersey , Kenilworth
Merck eager for deals, prospects for new drugs The Salt Lake Tribune
Switzerland , New Jersey , Kenilworth , Dunmore , Scranton
Strong sales of drugs, vaccines, propel Merck in 3Q Seattle Times
New Jersey , Wall Street , Kenilworth
Merck posts strong first-quarter profit, but revenue light apnews.com
New Jersey , Wall Street , Japan , Kenilworth
AA strong 2Q for Merck, outlook mixed apnewsarchive.com
New Jersey , Wall Street , Kenilworth
Merck profit soars on new drugs; CEO expects better The Columbian
HA Strong 2Q for Merck, Outlook Mixed hamodia.com
United Kingdom , New Jersey , Wall Street
Merck Seeks More Deals wsj.com
Merck continues study of new class of cholesterol drugs The Salt Lake Tribune
Kenilworth
Merck has strong fourth quarter as COVID-19 treatment debuts Seattle Times
New Jersey , Kenilworth , Wall Street
LEndocrinology Drugs Market Size, Key Opportunities, Strategic Assessment, Strong Revenue | Oprating Vendors: AbbVie, Merck, AstraZeneca, Eli Lilly, Sanofi, Novo Nordisk…liverpoolstudentmedia.com
Africa , Middle East , Mexico , Brazil , Latin America
BMerck and Gilead Sciences Sign Deals to Aid India's Covid-19 Fight barrons.com
India
Merck Profit Rises on Cancer Drugs, Vaccines wsj.com
Merck ups outlook, turns profit during global vaccine hunt Seattle Times
New Jersey , Kenilworth
Merck expects brunt of pandemic will strike this quarter journalrecord.com
Wall Street , New Jersey , Kenilworth
Merck posts global sales of $11B in third quarter The Wichita Eagle
China , Europe , New Jersey , Wall Street , Kenilworth